Can Clinical/ Endocrinal Surrogates Predict Specific Hormone Therapy in Nasopharyngeal Angiofibroma? Current Evidence

Area of Science:

• Endocrinology
• Otolaryngology
• Oncology

Background:

• Juvenile nasopharyngeal angiofibroma (JNA) is a rare, benign tumor.
• Hormone therapy (HT) is sometimes used for JNA, but its rationale requires further investigation.
• Understanding the hormonal environment in JNA is crucial for optimizing treatment.

Purpose of the Study:

• To investigate the pituitary axis and clinical profiles in JNA patients.
• To establish the dominant hormonal environment in JNA based on secondary sexual characteristics (SSC).
• To explore novel possibilities for hormone therapy in JNA.

Main Methods:

• Prospective observational study at a tertiary healthcare center.
• Analysis of 33 JNA patients, including age, SSC, tumor staging, and preoperative hormone profiles.
• Measurement of serum prolactin, testosterone, estrogens, progesterone, and luteinizing hormone (LH).

Main Results:

• Significant correlations found between LH, testosterone, and estrogens.
• LH/testosterone correlated with age, tumor weight, and most SSC.
• Estrogen levels correlated with age and most SSC, indicating potential estrogenic or androgenic predominance.

Conclusions:

• Secondary sexual characteristics can serve as clinical surrogate markers for hormonal activity in JNA.
• These surrogates may reflect receptor activity, providing a better rationale for selecting specific hormone therapies.
• This approach could lead to more personalized and effective HT for JNA.